The effects of siRNA-mediated inhibition of E2A-PBX1 on EB-1 and Wnt16b expression in the 697 pre-B leukemia cell line

Haematologica

Volumn 91, Issue 6, 2006, Pages 765-771

  Casagrande, Giovanna ^a   Te Kronnie, Geertruy ^a   Basso, Giuseppe ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

E2A PBX1; EB 1; Fusion gene; siRNA; Wnt16

Indexed keywords

CHIMERIC PROTEIN; HYBRID PROTEIN; ISOPROTEIN; MESSENGER RNA; MICROTUBULE ASSOCIATED PROTEIN; PROTEIN E2A PBX1; PROTEIN EB 1; PROTEIN WNT16B; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR E2A; UNCLASSIFIED DRUG; WNT PROTEIN;

APOPTOSIS; ARTICLE; CELLULAR DISTRIBUTION; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; DOWN REGULATION; DRUG DISTRIBUTION; DRUG EFFECT; DRUG INHIBITION; FLUORESCENCE ACTIVATED CELL SORTING; FLUORESCENCE MICROSCOPY; FUSION GENE; GENE SILENCING; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRE B LYMPHOCYTE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

APOPTOSIS; CELL LINE, TUMOR; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 19; DNA PRIMERS; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOPROTEINS; HUMANS; LEUKEMIA, PRE-B-CELL; MICROTUBULE-ASSOCIATED PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; RNA, SMALL INTERFERING; TRANSFECTION; TRANSLOCATION, GENETIC; WNT PROTEINS;

EID: 33745763860     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Carroll AJ, Crist WM, Parmley RT, Roper M, Cooper MD, Finley WH. Pre-B cell leukemia associated with chromosome translocation 1;19. Blood 1984;63:721-4.
2. Hunger SP, Fall MZ, Camitta BM, Carroll AJ, Link MP, Lauer SJ, et al. E2A-PBX1 chimeric transcript status at end of consolidation is not predictive of treatment outcome in childhood acute lymphoblastic leukemias with a t(1;19) (q23;p13): a Pediatric Oncology Group study. Blood 1998;91:1021-8.
3. Nourse J, Mellentin JD, Galili N, Wilkinson J, Stanbridge E, Smith SD, et al. Chromosomal translocation t(1;19) results in synthesis of a homeobox fusion mRNA that codes for a potential chimeric transcription factor. Cell 1990;60:535-45.
4. Frost BM, Forestier E, Gustafsson G, Nygren P, Hellebostad M, Jonmundsson G, et al. Translocation t(1;19) is related to low cellular drug resistance in childhood acute lymphoblastic leukaemia. Leukemia 2005;19:165-9.
5. Carroll WL, Raetz EA. Building better therapy for children with acute lymphoblastic leukemia. Cancer Cell 2005;7:289-91.
6. Hunger SF, Galili N, Carroll AJ, Crist WM, Link MP, Cleary ML. The t(1;19) (q23;p13) results in consistent fusion of E2A and PBX1 coding sequences in acute lymphoblastic leukemias. Blood 1991;77:687-93.
7. Aspland SE, Bendall HH, Murre C. The role of E2A-PBX1 in leukemogenesis. Oncogene 2001;20:5708-17.
8. Fu X, Kamps MP. E2a-Pbx1 induces aberrant expression of tissue-specific and developmentally regulated genes when expressed in NIH 3T3 fibroblasts. Mol Cell Biol 1997;17:1503-12.
9. Kamps MP, Baltimore D. E2A-Pbx1, the t(1;19) translocation protein of human pre-B-cell acute lymphocytic leukemia, causes acute myeloid leukemia in mice. Mol Cell Biol 1993;13:351-7.
10. Dedera DA, Waller EK, LeBrun DP, Sen-Majumdar A, Stevens ME, Barsh GS, et al. Chimeric homeobox gene E2A-PBX1 induces proliferation, apoptosis, and malignant lymphomas in transgenic mice. Cell 1993;74:833-43.
11. LeBrun DL, Cleary ML. Fusion with E2A alters the transcriptional properties of the homeodomain protein PBX1 in t(1;19) leukemias. Oncogene 1994;9:1641-7.
12. Lu Q, Wright DD, Kamps MP. Fusion with E2A converts the Pbx1 homeodomain protein into a constitutive transcriptional activator in human leukemias carrying the t(1;19) translocation. Mol Cell Biol 1994;14:3938-48.
13. Van Dijk MA, Voorhoeve PM, Murre C. Pbx1 is converted into a transcriptional activator upon acquiring the N-terminal region of E2A in pre-B-cell acute lympnoblastoid leukemia. Proc Natl Acad Sci USA 1993;90:6061-5.
14. McWhirter JR, Goulding M, Weiner JA, Chun J, Murre C. A novel fibroblast growth factor gene expressed in the developing nervous system is a down-stream target of the chimeric homeodomain oncoprotein E2A-Pbx1. Development 1997;124:3221-32.
15. Kadesch T. Helix-loop-helix proteins in the regulation of immunoglobulin gene transcription. Immunol Today 1992;13:31-6.
16. Bain G, Maandag EC, Izon DJ, Amsen D, Kruisbeek AM, Weintraub BC, et al. E2A proteins are required for proper B cell development and initiation of immunoglobulin gene rearrangements. Cell 1994;79:885-92.
17. Zhuang Y, Soriano P, Weintraub H. The helix-loop-helix gene E2A is required for B cell formation. Cell 1994;79:875-84.
18. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001;411:494-8.
19. Hannon GJ, Rossi JJ. Unlocking the potential of the human genome with RNA interference. Nature 2004;431:371-8.
20. Fu X, McGrath S, Pasillas M, Nakazawa S, Kamps MP. EB-1, a tyrosine kinase signal transduction gene, is transcriptionally activated in the t(1;19) subset of pre-B ALL, which express oncoprotein E2a-Pbx1. Oncogene 1999;18:4920-9.
21. Wodarz A, Nusse R. Mechanisms of Wnt signalling in development. Annu Rev Cell Dev Biol 1998;14:59-88.
22. Elbashir SM, Lendeckel W, Tuschl T. RNA interference is mediated by 21-and 22-nucleotide RNAs. Genes Dev 2001;15:188-200.
23. Gabert J, Beillard E, van der Velden VH, Bi W, Grimwade D, Pallisgaard N, et al. Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia: a Europe Against Cancer program. Leukemia 2003;17:2318-57.
24. McWhirter JR, Neuteboom ST, Wancewicz EV, Monia BP, Downing JR, Murre C. Oncogenic homeodomain transcription factor E2A-Pbx1 activates a novel WNT gene in pre-B acute lymphoblastoid leukemia. Proc Natl Acad Sci USA 1999;96:11464-9.
25. Polakis P. Wnt signalling and cancer. Genes Dev 2000;14:1837-51.
26. Reya T, O'Riordan M, Okamura R, Devaney E, Willert K, Nusse R, et al. Wnt signalling regulates B lymphocyte proliferation through a LEF-1 dependent mechanism. Immunity 2000;13:15-24.
27. Fear MW, Kelsell DP, Spurr NK, Barnes MR. Wnt-16a, a novel Wnt-16 isoform, which shows differential expression in adult human tissues. Biochem Biophys Res Commun 2000;278:814-20.
28. Mazieres J, You L, He B, Xu Z, Lee AY, Mikami I, et al. Inhibition of Wnt16 in human acute lymphoblastoid leukemia cells containing the t(1;19) translocation induces apoptosis. Oncogene 2005;24:5396-400.